Study Characteristics |
NHANES III 1988-1994 |
NHANES 1999-2000 |
NHANES 2001-2002 |
NHANES 2003-2004 |
NHANES 2005-2006 |
NHANES 2007-2008 |
Serum cotinine limit of detection (ng/mL) |
0.050 |
0.050 |
0.050 or 0.015 |
0.015 |
0.015 |
0.015 |
# of participants with serum cotinine values |
22,377 |
7,284 |
8,299 |
7,792 |
7,761 |
7,748 |
Serum cotinine values below the LOD (%) |
2,751
(12.3%) |
2,743
(37.7%) |
1,872
(22.6%) |
1,314
(16.9%) |
1,368
(17.6%) |
1,352
(17.5%) |
Total Urine NNAL limit of detection (ng/mL) |
- |
- |
- |
- |
- |
0.0006 |
# of participants with total urine NNAL values |
- |
- |
- |
- |
- |
7,170 |
Total urine NNAL values below the LOD (%) |
- |
- |
- |
- |
- |
3172
(44.2%) |
# of participants asked about workplace & household SHS smoke exposures |
33,994 |
9,965 |
11,039 |
10,122 |
10,348 |
10,149 |
Total Urinary NNAL, and corresponding Limits of Detection (LOD) |